Showing results (271-280 of 301) with videos related to

Sort By:
Pageof 31
The Oncologist|May 7, 2016
The PROFILE Feasibility Study: Targeted Screening of Men With a Family History of Prostate CancerElena Castro, Christos Mikropoulos, Elizabeth K Bancroft, et al.
BMJ Open|September 10, 2020
Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trialJulia Wade, Jenny Donovan, Athene Lane, et al.
Lancet (London, England)|November 20, 2012
Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trialDavid Neal Franz, Elena Belousova, Steven Sparagana, et al.
BMC Primary Care|March 20, 2025
Evaluation of the effectiveness and cost-effectiveness of the chronic disease co-care (CDCC) Pilot Scheme: a study protocolIvy L Mak, Kiki S N Liu, Zoey C T Wong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2010
The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative GroupAndrew J Vickers, Angel M Cronin, Monique J Roobol, et al.
World Journal of Urology|December 29, 2011
Importance of prostate volume in the European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators: results from the prostate biopsy collaborative groupMonique J Roobol, F H Schröder, Jonas Hugosson, et al.
Annals of the Child Neurology Society|December 27, 2024
Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy resultsJamie K Capal, David M Ritter, David Neal Franz, et al.
Digital Health|August 5, 2025
Digital assistive technologies for community-dwelling people with dementia: A systematic review of systematic reviews by the INTERDEM AI & assistive technology taskforceDavid Neal, Michael P Craven, Jane Cross, et al.
World Journal of Urology|January 3, 2012
Evaluating the PCPT risk calculator in ten international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
World Journal of Urology|April 25, 2012
Evaluating the Prostate Cancer Prevention Trial High Grade Prostate Cancer Risk Calculator in 10 international biopsy cohorts: results from the Prostate Biopsy Collaborative GroupDonna P Ankerst, Andreas Boeck, Stephen J Freedland, et al.
Pageof 31